Research Portal — Model TIM-100

Hydrogen Inhalation System with Inflatable Reservoir for Controlled FiH₂ Delivery

This inhalation system is designed to provide a controlled and consistent fraction of inspired hydrogen (FiH₂) by utilizing an inflatable reservoir bag. The system delivers a total gas flow rate of approximately 10 L/min, ensuring that individuals with a minute ventilation at or below this threshold receive a precise FiH₂ within the selected range (0.5–4% H₂).

Looking for consumer information? Visit our main website at inhaleh2.com.

Section 01

Device overview

This inhalation system is designed to provide a controlled and consistent fraction of inspired hydrogen (FiH₂) by utilizing an inflatable reservoir bag. The system delivers a total gas flow rate of approximately 10 L/min, ensuring that individuals with a minute ventilation at or below this threshold receive a precise FiH₂ within the selected range (0.5–4% H₂).

Key Functional Features

01

Inflatable Reservoir Bag

Ensures that every breath taken contains the intended FiH₂, mitigating variability associated with direct H₂ flow adjustments.

02

Adjustable Hydrogen Flow Rate (0.5–4%)

Provides precise control over H₂ delivery, accommodating different research parameters and physiological conditions.

03

Total Flow Rate of ~10 L/min

Maintains a stable FiH₂ regardless of variations in breathing patterns, tidal volume, or inhalation depth, as long as minute ventilation remains at or below 10 L/min.

04

Flammability and Safety Considerations

Hydrogen concentrations exceeding 4.6% in air enter the flammability range, with significantly increased risk above 10%. Most hospitals and clinics will not allow hydrogen inhalation devices exceeding 4% FiH₂ due to safety regulations.

Section 02

Therapeutic Considerations and FiH₂ Requirements

5–10 µM Min. intracellular H₂ concentration

A minimum intracellular H₂ concentration of approximately 5–10 µM is generally associated with an FiH₂ of at least 1%.

  • FiH₂ below 1% may not consistently achieve intracellular concentrations necessary for therapeutic effects.
  • Higher FiH₂ concentrations (e.g., 2–4%) can more reliably elevate tissue H₂ levels within the therapeutic range.
  • Exceeding 4% FiH₂ introduces safety risks, including the potential for hypoxia and, more critically, flammability concerns.

Understanding FiH₂, Flow Rate Selection, and Flammability Risks

  • A direct H₂ flow of 200 mL/min to several liters per minute may be required to achieve an FiH₂ of 4%, depending on individual ventilation rates.
  • Flammability risks increase significantly when FiH₂ exceeds 4.6%, with an even greater hazard above 10%.
  • Most clinical and research environments prohibit hydrogen inhalation devices exceeding 4% FiH₂ due to these safety concerns.
  • The inflatable reservoir system ensures stable FiH₂ within a safe and controlled range, optimizing therapeutic potential while adhering to safety and regulatory standards.

Regulatory and Clinical Considerations

Most hospitals, clinics, and research institutions follow strict safety guidelines that prohibit hydrogen inhalation systems exceeding 4% FiH₂. This device is designed to comply with these restrictions while providing reliable and reproducible hydrogen delivery.

Section 03

Inhale H₂ specification sheet

Included components

User manual Mask / hose Cannula / hose / adapter AC power cord Spare HEPA filter cartridge Spare breathing bags

General information

Model TIM-100
Type Hydrogen inhalation machine
H₂ production method PEM electrolysis
Intended use Pre-clinical & clinical research
Compliance UL · CE

Features

  • Delivers a non-flammable hydrogen gas mixture
  • Infinite adjustable variability — 0.5% to 4% H₂ (vol/vol)
  • Lightweight & portable
  • Replaceable supplemental breathing bags
  • Quiet operation
  • Simple digital-dial user interface
  • Built-in timer function
  • Lightweight mask or optional cannula

Technical specifications

Operating temperature 10–40 °C
Storage −10 to 50 °C, 0–95% RH
User interface Digital display + knob
Electrolytic cell SPE-PEM (Pt-Ti, Nafion 117)
Hydrogen purity 99.995%
Hydrogen % 0.5 – 4% (adjustable)
Output flow rate 8 500 – 10 000 mL/min
Output pressure 0.1 – 0.5 MPa
Electrolysis water Distilled
Reservoir capacity 1 L
Room-air filtration HEPA (replaceable)
Breathing bag 3 L
Electrical 120–240 VAC, 50/60 Hz · 100 W
Power supply SMPS

Internal sensors

Hydrogen output % monitor
Hydrogen leak detection
Output-air flow monitor
Water reservoir level
Water reservoir TDS
PEM temperature
Water leak detection
Cabinet tip-over
Cabinet ventilation fan flow
HEPA filter installed check

Required H₂ flow vs. ventilation rate

Ventilation rate (mL/sec) Required H₂ flow rate (mL/min) Required H₂ Flow Rate vs. Ventilation Target FiH₂ 1% FiH₂ 2% FiH₂ 4% FiH₂

Drop your real flow chart at /wp-content/themes/inhaleh2-research-child/assets/flow-figure.png to replace this placeholder.

Required hydrogen flow rates (mL/min) to achieve target FiH₂ of 1%, 2%, and 4% across ventilation rates of 200–2000 mL/sec. The shaded gradient (beginning at 600 mL/min) represents relative flammability risk; intensity increases as flow rates approach the lower flammability limit (LFL) of 4.6%.
Section 04

Purpose

This platform provides technical information, specifications, and usage rationale for a hydrogen gas inhalation system designed to deliver controlled fractions of inspired hydrogen (FiH₂) for preclinical and clinical research. The goal is to support reproducibility, safety, and translational relevance across diverse experimental models.

System Description

  • Reservoir volume: 3 L, capable of accommodating even maximal human tidal volumes
  • Hydrogen gas flow rate: Adjustable, depending on desired FiH₂
  • Total output flow: ~10 L/min (air + H₂), nearly double the average adult minute ventilation
  • H₂ equivalence: Equivalent to ~7.2 L/min of pure hydrogen or ~180 L/min of 4% H₂ mixture*
  • Delivery interface: One-way mask, nasal cannula, or enclosed chamber. The one-way mask ensures all inspired air is drawn from the reservoir, maintaining FiH₂ equal to the concentration in the bag
  • Recommended use: Inhalation studies in rodents, large animals, cell culture chambers, and human subjects

*In a theoretical example, if an individual were to inhale 3 L of gas over a 1-second inhalation, achieving a consistent FiH₂ of 4% would require 120 mL of hydrogen to be delivered within that second — a continuous flow rate of 7.2 L/min of pure H₂. Ensuring a premixed reservoir concentration avoids such real-time delivery demands while maintaining dose accuracy.

This configuration ensures that every breath, regardless of tidal volume, inspiratory duration, or breathing pattern, contains the desired FiH₂. Hydrogen concentration in the mask, lungs, and during exhalation remains at or below 4%, well within accepted safety margins.

Section 05

Rationale for Controlled FiH₂ Delivery

Hydrogen gas exerts biological effects only once a threshold concentration is reached within cells and tissues. Based on solubility and diffusion characteristics, this threshold is estimated to correspond to an FiH₂ of approximately ≥1%, yielding intracellular concentrations around 5–10 µM.

Unregulated delivery systems (e.g., direct H₂ flow without air mixing or volume matching) produce highly variable FiH₂ depending on subject ventilation rate, tidal volume, inspiratory time, and breathing frequency. Such variability can lead to under- or over-dosing, poor reproducibility, or unsafe conditions (e.g., oxygen displacement, flammability).

The controlled-reservoir approach facilitates dose-dependent studies in cellular, animal, and human models where concentration-response relationships are a critical experimental variable.

Section 06

Applications

Rodent and Animal Studies

The inflatable-bag system is compatible with individual cages or sealed exposure chambers. It maintains a uniform, non-flammable H₂ concentration within the air volume, enabling reproducible dosing across animals. This is particularly valuable for:

  • Studies on ischemia-reperfusion injury
  • Models of inflammation, neurodegeneration, or metabolic dysfunction
  • Dose-response investigations using varying FiH₂ concentrations

Cell Culture and In Vitro Applications

By providing controlled FiH₂ environments for gas-permeable cell culture incubators or sealed chambers, this system supports research that is mechanistically aligned with in vivo and clinical applications.

  • Enables direct comparison between in vitro and in vivo findings
  • Supports mechanistic studies on H₂ signaling pathways
  • Avoids hypoxia or hyperoxia effects common in high-H₂ setups

Human Subject Research

The system ensures safe FiH₂ levels below the lower flammability limit (LFL) of hydrogen in air (4.6%). Regulatory bodies and institutional review boards (IRBs) generally permit H₂ inhalation studies using FiH₂ ≤ 4%.

Section 07

Safety & compliance parameters

Parameter Value / Range Notes
Hydrogen concentration (FiH₂) 0.5 – 4.0% Adjustable by flow-mixing ratio
Total gas flow ~10 L/min Matches or exceeds typical minute ventilation to ensure accurate FiH₂
Flammability threshold (H₂ in air) 4.6% (lower limit) System engineered to remain below LFL
Power requirements Inflatable bag: none
System: standard mains
Inflatable bag operates passively; active components require external power
Interface options One-way mask · cannula · enclosure One-way mask ensures all inspired air comes from reservoir to maintain precise FiH₂

Supporting Research Standards

This system facilitates adherence to experimental principles such as:

  • Reproducibility across trials and subjects
  • Dose fidelity and quantification
  • Translational alignment between cell, animal, and human models
  • Compatibility with institutional safety protocols and IRB guidelines
Section 08

Downloads and Technical Documentation

The full research kit is provided to verified academic and clinical collaborators. Request access below.

  • PDF System Specification Sheet
  • XLSX Flow Rate to FiH₂ Conversion Table
  • PDF Safety and Flammability Guidelines
  • DOCX Protocol Templates for Rodent and Cell Studies
  • PDF Peer-Reviewed Literature Reference List
Request the full research kit
Contact

Contact

For technical details, academic collaboration, or integration into research protocols, please reach out via email.

research@inhaleh2.com

This device is protected under an active international patent application filed through the World Intellectual Property Organization (WIPO-PCT). The design, technology, and functionality are legally protected across more than 150 countries. Unauthorized copying, replication, or reproduction is strictly prohibited and enforceable under international law.